Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

Author:

João Esaú C,Morrison R Leavitt,Shapiro David E,Chakhtoura Nahida,Gouvèa Maria Isabel S,de Lourdes B Teixeira Maria,Fuller Trevon L,Mmbaga Blandina T,Ngocho James S,Njau Boniface N,Violari Avy,Mathiba Ruth,Essack Zaakirah,Pilotto Jose Henrique S,Moreira Luis Felipe,Rolon Maria Jose,Cahn Pedro,Prommas Sinart,Cressey Timothy R,Chokephaibulkit Kulkanya,Werarak Peerawong,Laimon Lauren,Hennessy Roslyn,Frenkel Lisa M,Anthony Patricia,Best Brookie M,Siberry George K,Mirochnick Mark

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference27 articles.

1. Global AIDS update 2019,2019

2. Recommendations for the use of antiretroviral drugs in pregnant women with HIV Infection and interventions to reduce perinatal HIV transmission in the United States,2019

3. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception;Mandelbrot;Clin Infect Dis,2015

4. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial;Lennox;Lancet,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3